Biogeography of the Oral Microbiome

A cross-sectional study to metatranscriptomically analyze and compare the oral microbiome in different environmental niches within the oral cavity.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Oral Microbiome

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Viome Life Sciences

Bothell, Washington, 98011, United States

About this study

This study will collect samples from participants meeting the eligibility criteria over the span of 3 months. Samples will be collected from multiple locations within the oral cavity and metatranscriptomically analyzed.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

18 years old or older

Exclusion criteria

Positive SARS-CoV-2 test result, if performed
Antibiotic use in the previous 30 days
Mouthwash use in the previous 6 months

Treatment and study plan

Primary outcomes

Species richness in multiple oral locations

Time frame: 3 months

Number of species present in different areas swabbed in the oral cavity.

Secondary outcomes

KO richness of multiple oral locations

Time frame: 3 months

KO richness of multiple areas swabbed in the oral cavity.

Sponsors and collaborators

Lead sponsor

Viome

Industry

Registry information

Official study title

Biogeography of the Oral Microbiome Using Metatranscriptomic Analyses

Important dates

Study start: 2021
Primary completion: 2021
Study completion: 2021
First posted: Jan 5, 2023
Registry last updated: Jan 5, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed